Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis

Stem Cells and Development

Volumn 22, Issue 6, 2013, Pages 845-854

  Li, Tingfen ^a   Yan, Yongmin ^a   Wang, Bingying ^a   Qian, Hui ^a   Zhang, Xu ^a   Shen, Li ^a   Wang, Mei ^a   Zhou, Ying ^a   Zhu, Wei ^a   Li, Wei ^a,b   Xu, Wenrong ^a  

^a JIANGSU UNIVERSITY   (China)

^b Jiangsu Public Stem Cell Engineering Technology Research Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; NERVE CELL ADHESION MOLECULE; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL PROTECTION; CELL TRANSPLANTATION; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; EXOSOME; HEPATITIS; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER CELL; LIVER FIBROSIS; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SURFACE PROPERTY; UMBILICAL CORD;

ANIMALS; CARBON TETRACHLORIDE; CELL DIFFERENTIATION; CELL EXTRACTS; CELL LINE; CELL SHAPE; COLLAGEN TYPE I; COLLAGEN TYPE III; EPITHELIAL-MESENCHYMAL TRANSITION; EXOSOMES; HUMANS; LIVER; LIVER CIRRHOSIS; MESENCHYMAL STROMAL CELLS; MICE; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA1; UMBILICAL CORD;

EID: 84876241933     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0395     Document Type: Article

References (35)

1. Snowdon VK and JA Fallowfield. (2011). Models and mechanisms of fibrosis resolution. Alcohol Clin Exp Res 35:794-799.
2. Ghatak S, A Biswas, GK Dhali, A Chowdhury, JL Boyer and A Santra. (2011). Oxidative stress and hepatic stellate cell activation are key events in arsenic induced liver fibrosis in mice. Toxicol Appl Pharmacol 251:59-69.
3. Domitrović R and H Jakovac. (2011). Effects of standardized bilberry fruit extract on resolution of CCl4-induced liver fi-brosis in mice. Food Chem Toxicol 49:848-854.
4. Malhi H and GJ Gores. (2008). Cellular and molecular mechanisms of liver injury. Gastroenterology 134:1641-1654.
5. Zeisberg M, C Yang, M Martino, MB Duncan, F Rieder, H Tanjore and R Kalluri. (2007). Fibroblasts derive from he-patocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 282:23337-23347.
6. Iwano M, D Plieth, TM Danoff, C Xue, H Okada and EG Neilson. (2002). Evidence that fibroblasts derive from epi-thelium during tissue fibrosis. J Clin Invest 110:341-350.
7. Chen YL, J Lv, XL Ye, MY Sun, Q Xu, CH Liu, LH Min, HP Li, P Liu and X Ding. (2011). Sorafenib inhibits tansforming growth factor ß1-mediated epithelial-mesenchymal transi-tion and apoptosis in mouse hepatocytes. Hepatology 53: 1708-1718.
8. Kaimori A, J Potter, JY Kaimori, C Wang, E Mezey and A Koteish. (2007). Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse he-patocytes in vitro. J Biol Chem 282:22089-22101.
9. Kanazawa H, Y Fujimoto, T Teratani, J Iwasaki, N Kasahara, K Negishi, T Tsuruyama, S Uemoto and EY Kobayashi. (2011). Bone marrow-derived mesenchymal stem cells ame-liorate hepatic ischemia reperfusion injury in a rat model. PLoS One 6:e19195.
10. Yan Y, W Xu, H Qian, Y Si, W Zhu, H Cao, H Zhou and F Mao. (2009). Mesenchymal stem cells from human umbilical cords ameliorate mouse hepatic injury in vivo. Liver Int 29:356-365.
11. Xu H, H Qian, W Zhu, X Zhang, Y Yan, F Mao, M Wang, H Xu and W Xu. (2012). Mesenchymal stem cells relieve fibrosis of Schistosoma japonicum-induced mouse liver injury. Exp Biol Med (Maywood) 237:585-592.
12. Tögel F, K Weiss, Y Yang, Z Hu, P Zhang and C Westenfelder. (2007). Vasculotropic, paracrine actions of infused mesenchy-mal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 292:F1626-F1635.
13. Camussi G, MC Deregibus and C Tetta. (2010). Paracrine/ endocrine mechanism of stem cells on kidney repair: role of microvesicle-mediated transfer of genetic information. Curr Opin Nephrol Hypertens 19:7-12.
14. Qin ZH, JF Xu, JM Qu, J Zhang, Y Sai, CM Chen, L Wu and L Yu. (2012). Intrapleural delivery of MSCs attenuates acute lung injury by paracrine/endocrine mechanism. J Cell Mol Med [Epub ahead of print]; DOI: 10.1111/j.1582-4934 .2012.01597.x.
15. Schorey JS and S Bhatnagar. (2008). Exosome function: from tumor immunology to pathogen biology. Traffic 9:871-881.
16. Bruno S, C Grange, MC Deregibus, RA Calogero, S Saviozzi, F Collino, L Morando, A Busca, M Falda, et al. (2009). Me-senchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 20:1053-1067.
17. Gatti S, S Bruno, MC Deregibus, A Sordi, V Cantaluppi, C Tetta and G Camussi. (2011). Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant 26:1474-1483.
18. Bruno S, C Grange, F Collino, MC Deregibus, V Canta-luppi, L Biancone, C Tetta and G Camussi. (2012). Micro-vesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. PLoS One 7:e33115.
19. Lai RC, F Arslan, MM Lee, NS Sze, A Choo, TS Chen, M Salto-Tellez, L Timmers, CN Lee, et al. (2010). Exosome se-creted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 4:214-222.
20. Lai RC, TS Chen and SK Lim. (2011). Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen Med 6:481-492.
21. Qian H, H Yang, W Xu, Y Yan, Q Chen, W Zhu, H Cao, Q Yin, H Zhou, F Mao and Y Chen. (2008). Bone marrow mesenchymal stem cells ameliorate rat acute renal failure by differentiation into renal tubular epithelial-like cells. Int J Mol Med 22:325-332.
22. Chen Y, H Qian, W Zhu, X Zhang, Y Yan, S Ye, X Peng, W Li and W Xu. (2011). Hepatocyte growth factor modification promotes the amelioration effects of human umbilical cord mesenchymal stem cells on rat acute kidney injury. Stem Cell Dev 20:103-113.
23. Cao H, H Qian, W Xu, W Zhu, X Zhang, Y Chen, M Wang, Y Yan and Y Xie. (2010). Mesenchymal stem cells derived from human umbilical cord ameliorate ischemia/reperfusion-induced acute renal failure in rats. Biotechnol Lett 32:725-732.
24. Qiao C, W Xu, W Zhu, J Hu, H Qian, Q Yin, R Jiang, Y Yan, F Mao, et al. (2008). Human mesenchymal stem cells isolated from the umbilical cord. Cell Biol Int 32:8-15.
25. Zhu W, L Huang, Y Li, X Zhang, J Gu, Y Yan, X Xu, M Wang, H Qian and W Xu. (2012). Exosomes derived from human bone marrow mesenchymal stem cells promote tu-mor growth in vivo. Cancer Lett 315:28-37.
26. Li F, CL Zhu, H Zhang, H Huang, Q Wei, X Zhu and XY Cheng. (2012). Role of hyaluronic acid and laminin as serum markers for predicting significant fibrosis in patients with chronic hepatitis B. Braz J Infect Dis 16:9-14.
27. Zhang Z, H Lin, M Shi, R Xu, J Fu, J Lv, L Chen, S Lv, Y Li, et al. (2012). Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. J Gastroenterol Hepatol 2:112-120.
28. Tsai PC, TW Fu, YM Chen, TL Ko, TH Chen, YH Shih, SC Hung and YS Fu. (2009). The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis. Liver Transpl 15:484-495.
29. Zhang S, L Chen, T Liu, B Zhang, D Xiang, ZG Wang and Y Wang. (2012). Human umbilical cord matrix stem cells efficiently rescue acute liver failure through paracrine effects rather than hepatic differentiation. Tissue Eng Part A 18: 1352-1364.
30. Meirelles Lda S, AM Fontes, DT Covas and AI Caplan. (2009). Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 20:419-427.
31. Herrera MB, V Fonsato, S Gatti, MC Deregibus, A Sordi, D Cantarella, R Calogero, B Bussolati, C Tetta and G Camussi. (2010). Human liver stem cell-derived microvesicles accel-erate hepatic regeneration in hepatectomized rats. J Cell Mol Med 14:1605-1618.
32. Franquesa M, MJ Hoogduijn, O Bestard and JM Grinyó. (2012). Immunomodulatory effect of mesenchymal stem cells on B cells. Front Immunol 3:212.
33. Mokarizadeh A, N Delirezh, A Morshedi, G Mosayebi, AA Farshid and K Mardani. (2012). Microvesicles derived from mesenchymal stem cells: potent organelles for induction of tolerogenic signaling. Immunol Lett 147:47-54.
34. Massagué J and YG Chen. (2000). Controlling TGF-beta signaling. Genes Dev 14:627-644.
35. Cho HJ, KE Baek, S Saika, MJ Jeong and J Yoo. (2007). Snail is required for transforming growth factor-beta-induced epithelial-mesenchymal transition by activating PI3 kinase/ Akt signal pathway. Biochem Biophys Res Commun 353: 337-343.